Labshake search
Citations for R&D Systems :
101 - 150 of 3878 citations for Ciprofloxacin Hcl 100 Ug Ml In Methanol 2 3 Carboxyl 13C3 99%; Quinoline 15N 98% since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... and 25 ng/ml rhIL-3 (R&D Systems). Macrophage precursor cells could be routinely harvested from dishes containing EBs every 6/7 days for up to 3/4 months ...
-
bioRxiv - Cell Biology 2023Quote: ... and 1 ng/ml IL-3 (R&D Systems) to induce cell proliferation ...
-
bioRxiv - Physiology 2022Quote: ... Dectin-2 (1:100, clone 17611; R&D Systems), TLR2 (1:200 ...
-
bioRxiv - Immunology 2023Quote: ... and 50 U/mL Interleukin-2 (IL-2, R&D Systems). Pre-isolated NK cells were thawed and co-cultured at a 1:1 effector:target (E:T ...
-
bioRxiv - Developmental Biology 2023Quote: ... 100 ng/mL rhNOGGIN (produced in-house) or 100 ng/mL BMP4 (R&D Systems Cat#314-BP-050) was added to human lung ALI explant media.
-
Suppression of the Integrated Stress Response in Islet β Cells Decreases Risk of Autoimmune DiabetesbioRxiv - Cell Biology 2023Quote: ... and 100 ng/mL mouse IFN-γ (R&D Systems; 485-MI-100). For experiments involving human islets and EndoC-βH1 cells ...
-
bioRxiv - Pharmacology and Toxicology 2024Quote: ... and 100 ng/mL of BMP2 (R&D Systems, cat # 355-BM-100) for 3 days ...
-
bioRxiv - Bioengineering 2019Quote: hESCs were differentiated to SC-β cells as previously described9 by culturing in the following conditions in order: Stage 1: 3 d with 100 ng/ml Activin A (R&D Systems; 338-AC) and 3 μM CHIR99021 (Stemgent ...
-
bioRxiv - Cancer Biology 2023Quote: ... cells were treated with 3 uM CHIR, 300 nM LDN193189 (LDN, Axon, Scottsdale, AZ) and 100 ng/mL epidermal growth factor (EGF, R&D systems, Minneapolis, MN) in Advanced DMEM/F12 (Invitrogen ...
-
bioRxiv - Cell Biology 2021Quote: ... 100 ng/ml Act A + 50 ng/ml Wnt3A (R&D Systems), (iii ...
-
bioRxiv - Developmental Biology 2019Quote: ... 25 ng/ml FGF2 and 100 ng/ml FGF10 (R&D Systems). The explants were incubated at 37°C ...
-
bioRxiv - Cell Biology 2022Quote: ... for 2 days in R10 medium supplemented with IL-2 (10ng/ml, 402-ML-020, R&D Systems) for 2 days ...
-
bioRxiv - Immunology 2021Quote: ... 10 U/mL IL-2 from R&D Systems (1150-ML), 5 U/mL IL-12 p70 from PeproTech (210-12) ...
-
bioRxiv - Developmental Biology 2020Quote: ... 2 ng/ml HGF (R&D Systems) and 50 μM Y-27632 (Tocris Bioscience) ...
-
bioRxiv - Systems Biology 2020Quote: ... GDNF (2 ng/mL, R&D Systems), NT3 (10 ng/µL ...
-
bioRxiv - Developmental Biology 2022Quote: ... 2 ng/ml HGF (R&D Systems) and 50 μM Y-27632 (Tocris Bioscience) ...
-
bioRxiv - Immunology 2020Quote: ... 5ng/mL hIL-2 (R&D Systems) and 100ng/mL Mega-CD40 ligand (Enzo Life Sciences ...
-
bioRxiv - Neuroscience 2021Quote: ... GDNF (2 ng/mL, R&D Systems), NT3 (10 ng/μL ...
-
bioRxiv - Cell Biology 2022Quote: ... 20ng/ml FGF-2 (R&D systems), 5μM Y-27632 (Geron) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 ng/ml TGFB1 (R&D Systems) and 0.4 μM IWP2 (Selleck Chemicals) ...
-
bioRxiv - Immunology 2021Quote: ... and 2 ng/ml IL-2 (carrier-free; Tocris R&D Systems). Cells treated with only these functioned as the mock control ...
-
bioRxiv - Developmental Biology 2020Quote: ... Activin A (100 ng/ml, R&D Systems) and a treatment for the first day ...
-
bioRxiv - Cancer Biology 2020Quote: ... 100 ng/mL GM-CSF (R&D Systems) and 10 ng/mL IL-4 (R&D Systems) ...
-
bioRxiv - Immunology 2021Quote: ... 100 ng/mL Activin-A (R&D Systems), and 3 mM CHIR (StemCell Technologies)) ...
-
bioRxiv - Cell Biology 2021Quote: ... 100 ng/mL Activin A (R&D Systems), 25 ng/mL mouse Wnt3a (R&D Systems).
-
bioRxiv - Microbiology 2020Quote: ... 100 ng/mL rIL-1β (R&D Systems), 5 µM caspase inhibitors zVAD-fmk ...
-
bioRxiv - Neuroscience 2020Quote: ... and 100 ng/mL Noggin (R&D systems), and the medium was replenished every day ...
-
bioRxiv - Neuroscience 2022Quote: ... 100 ng/mL Activin A (R&D systems), and 3 μM of CHIR99021 (Cayman Chemical ...
-
bioRxiv - Pathology 2022Quote: ... 100 ng/mL interferon γ (R&D Systems), or serum depletion for 6 hrs ...
-
bioRxiv - Molecular Biology 2020Quote: ... Activin-A (100 ng/ml) (R&D Systems) was treated for 30 min ...
-
bioRxiv - Immunology 2020Quote: ... IL-27 (100 ng/ml, R&D Systems), IFNγ (30 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... 100 ng/mL IFN-γ (R&D systems) was added to the cells to generate M1 macrophages ...
-
bioRxiv - Cell Biology 2021Quote: ... 100 ng/ml Wnt-3a (R&D systems) and 100 nM SMO agonist (SAG ...
-
bioRxiv - Neuroscience 2023Quote: ... 100 ng/mL noggin (R&D Systems, 3344NG050) and 50 units/mL-50ug/mL Penicillin-Streptomycin (ThermoFisher ...
-
bioRxiv - Neuroscience 2023Quote: ... 100 ng/mL noggin (R&D Systems, 3344NG050), and 40 ng/mL T3 (Sigma ...
-
bioRxiv - Cell Biology 2023Quote: ... 100 ng/ml human Wnt3a (R&D Systems) was added ...
-
bioRxiv - Microbiology 2023Quote: ... 100 ng/mL recombinant TNFα (R&D Systems) with 2 μM Birinapant Smac mimetic (MedChemExpress ...
-
bioRxiv - Cancer Biology 2023Quote: ... 100 ng/ml R-Spondin1 (R&D Systems), 50 ng/ml EGF (Peprotech) ...
-
bioRxiv - Cell Biology 2022Quote: ... Noggin (100 ng mL-1, R&D Systems), and R-spondin-1 (0.5 μg mL-1 ...
-
THE OLFACTORY RECEPTOR Olfr78 REGULATES DIFFERENTIATION OF ENTEROCHROMAFFIN CELLS IN THE MOUSE COLONbioRxiv - Cell Biology 2023Quote: ... 100 ng/ml Rspondin 1 (R&D systems), 100 ng/ml noggin (both from Peprotech) ...
-
bioRxiv - Immunology 2022Quote: ... 100 ng/ml Wnt-3a (R&D systems) or 100 nM SMO agonist (SAG ...
-
bioRxiv - Immunology 2023Quote: ... Noggin (100 ng ml−1) (R&D system) and R-Spondin (500 ng ml−1 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and 100 ng/mL IFNγ (R&D Systems) or 50 ng/mL and IL4 and IL13 (R&D Systems ...
-
bioRxiv - Synthetic Biology 2023Quote: ... 100 ng/mL TGF-α (R&D Systems), and 100 ng/mL TNF-α (R&D Systems ...
-
bioRxiv - Cancer Biology 2023Quote: ... 100 ng/ml Wnt-3A (R&D Systems), 1 µM Prostaglandin E2 and 0.5 µM A83-01 (Tocris Bioscience).
-
bioRxiv - Developmental Biology 2023Quote: ... and 100 ng/ml Noggin (R&D Systems). From day 6 to day 9 ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... 100 ng/mL Wnt1-sFRP1 (R&D Systems) ± 500 ng/mL recombinant sclerostin (Peprotech).
-
bioRxiv - Neuroscience 2024Quote: ... and 100 ng/mL CX3CL1 (R&D Systems) were added to Microglia medium to mimic a brain-like environment ...
-
bioRxiv - Cell Biology 2021Quote: ... 5 ng/mL recombinant murine IL-3 (R&D Systems, and 5% stem cell factor-containing supernatant from CHO-KL cells for 4-6 weeks until maturation ...
-
bioRxiv - Bioengineering 2021Quote: ... and 3 U/mL EPO (R&D Systems 287-TC). Cells were cultured for 7 days followed EHT and assessed using by flow cytometry.